(July 18, 2017) Partnership Agreement with Eisai Co., Ltd. on the Promotion of the Construction of the Community-Based Care System in Inagi City

Tweet on Twitter
Share on Facebook
Share on Line

Page ID 1009456 Update Date Reiwa 7, February 4

PrintPrint in large text

In Inagi City, we are promoting the establishment of a community-based care system that provides integrated support for medical care, nursing care, and prevention, so that Older Adults can continue to live safely in their familiar communities.
We have concluded a partnership agreement with Eisai Co., Ltd., a pharmaceutical company, regarding the promotion of the establishment of the community-based care system in Inagi City, and we will continue to deepen our collaboration and cooperation with the business operators involved in the agreement to advance the establishment of the community-based care system.

Signing Ceremony of the Partnership Agreement on the Promotion of the Construction of the Community-Based Integrated Care System in Inagi City

Implementation Date: July 18, 2017
Business Operators

Eisai Co., Ltd.

Photo: Signing ceremony with Eisai Co., Ltd.
Eisai Co., Ltd.
Photo: Ceremony of Agreement Signing
Ceremony of Agreement Conclusion

Agreement Details

Eisai Co., Ltd.

The agreement with Eisai Co., Ltd. aims to promote collaboration and cooperation in efforts for the early detection and treatment of dementia within Inagi City, contributing to the creation of a community where individuals with dementia can live with peace of mind. By fostering close collaboration and cooperation, we aim to advance the establishment of a community-based integrated care system, facilitating the development of a community where individuals with dementia can continue to live safely.

Specific Cooperation Details

  1. Information provision as an observer for the Dementia Coordinator Liaison Meeting
  2. Cooperation and information provision for training on dementia for medical and nursing care professionals
  3. Provide information from other municipalities with which we have agreements to the early-stage dementia support team, etc.

Note: Pfizer Inc., which also concluded a partnership agreement on the same day, terminated the partnership agreement as of October 15, 2021.

Please let us know your feedback on how to make our website better.

Was the content of this page easy to understand?
Was this page easy to find?


We cannot respond to comments entered in this section. Also, please do not enter personal information.

Inquiries about this page

Inagi City Policy and Planning Division
〒206-8601 2111 Higashi-Naganuma, Inagi City, Tokyo
Phone number: 042-378-2111 Fax number: 042-377-4781
Contact Inagi City Policy and Planning Division